共 50 条
Homozygous Dkk1 Knockout Mice Exhibit High Bone Mass Phenotype Due to Increased Bone Formation
被引:0
|作者:
Michelle M. McDonald
Alyson Morse
Aaron Schindeler
Kathy Mikulec
Lauren Peacock
Tegan Cheng
Justin Bobyn
Lucinda Lee
Paul A. Baldock
Peter I. Croucher
Patrick P. L. Tam
David G. Little
机构:
[1] The Children’s Hospital at Westmead,Orthopaedic Research & Biotechnology Unit
[2] The Garvan Institute for Medical Research,Bone Biology Division
[3] University of Sydney,Discipline of Paediatrics and Child Health, Sydney Medical School
[4] The Children’s Medical Research Institute,Embryology Unit
[5] University of Sydney,Discipline of Anatomy and Histology, School of Medical Sciences, Sydney Medical School
来源:
关键词:
Dkk1;
Wnt-signalling;
Bone;
High bone mass;
Knockout model;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Wnt antagonist Dkk1 is a negative regulator of bone formation and Dkk1+/− heterozygous mice display a high bone mass phenotype. Complete loss of Dkk1 function disrupts embryonic head development. Homozygous Dkk1−/− mice that were heterozygous for Wnt3 loss of function mutation (termed Dkk1 KO) are viable and allowed studying the effects of homozygous inactivation of Dkk1 on bone formation. Dkk1 KO mice showed a high bone mass phenotype exceeding that of heterozygous mice as well as a high incidence of polydactyly and kinky tails. Whole body bone density was increased in the Dkk1 KO mice as shown by longitudinal dual-energy X-ray absorptiometry. MicroCT analysis of the distal femur revealed up to 3-fold increases in trabecular bone volume and up to 2-fold increases in the vertebrae, compared to wild type controls. Cortical bone was increased in both the tibiae and vertebrae, which correlated with increased strength in tibial 4-point bending and vertebral compression tests. Dynamic histomorphometry identified increased bone formation as the mechanism underlying the high bone mass phenotype in Dkk1 KO mice, with no changes in bone resorption. Mice featuring only Wnt3 heterozygosity showed no evident bone phenotype. Our findings highlight a critical role for Dkk1 in the regulation of bone formation and a gene dose-dependent response to loss of DKK1 function. Targeting Dkk1 to enhance bone formation offers therapeutic potential for osteoporosis.
引用
收藏
页码:105 / 116
页数:11
相关论文